Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 272

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Application of ’omics technologies to biomarker discovery in inflammatory lung diseases

Open access
Wheelock, Craig E., Goss, Victoria M., Balgoma, David, Nicholas, Ben, Brandsma, Joost, Skipp, Paul J., Snowden, Stuart, Burg, Dominic, D'Amico, Arnaldo, Horvath, Ildiko, Chaiboonchoe, Amphun, Ahmed, Hassan, Ballereau, Stéphane, Rossios, Christos, Chung, Kian Fan, Montuschi, Paolo, Fowler, Stephen J., Adcock, Ian M., Postle, Anthony D., Dahlén, Sven-Erik, Rowe, Anthony, Sterk, Peter J., Auffray, Charles, Djukanović, Ratko, the U-BIOPRED Study Group·2013·European Respiratory Journal

Abstract

Inflammatory lung diseases are highly complex in respect of pathogenesis and relationships between inflammation, clinical disease and response to treatment. Sophisticated large-scale analytical methods to quantify gene expression (transcriptomics), proteins (proteomics), lipids (lipidomics) and metabolites (metabolomics) in the lungs, blood and urine are now available to identify biomarkers that define disease in terms of combined clinical, physiological and patho-biological abnormalities. The aspiration is that these approaches will improve diagnosis,i.e.define pathological phenotypes, and facilitate the monitoring of disease and therapy, and also, unravel underlying molecular pathways. Biomarker studies can either select predefined biomarker(s) measured by specific methods or apply an “unbiased” approach involving detection platforms that are indiscriminate in focus. This article reviews the technologies presently available to study biomarkers of lung disease within the ’omics field. The contributions of the individual ’omics analytical platforms to the field of respiratory diseases are summarised, with the goal of providing background on their respective abilities to contribute to systems medicine-based studies of lung disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/09031936.00078812

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 272

Metadata

Authors
Wheelock, C. E., Goss, V. M., Balgoma, D., Nicholas, B., Brandsma, J., Skipp, P. J., Snowden, S., Burg, D., D'Amico, A., Horvath, I., Chaiboonchoe, A., Ahmed, H., Ballereau, S., Rossios, C., Chung, K. F., Montuschi, P., Fowler, S. J., Adcock, I. M., Postle, A. D., Dahlén, S.-E., Rowe, A., Sterk, P. J., Auffray, C., Djukanović, R., & the U-BIOPRED Study Group
Venue
European Respiratory Journal
Published
2013-02-08
Volume
42
Issue
3
Pages
802-825
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2111793469
Cited by
272
References
20
FWCI
19.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Application of ’omics technologies to biomarker discovery in inflammatory lung diseases. https://app.cochat.ai/papers/10.1183/09031936.00078812
The paper
Wheelock, C. E., Goss, V. M., Balgoma, D., Nicholas, B., Brandsma, J., Skipp, P. J., Snowden, S., Burg, D., D'Amico, A., Horvath, I., Chaiboonchoe, A., Ahmed, H., Ballereau, S., Rossios, C., Chung, K. F., Montuschi, P., Fowler, S. J., Adcock, I. M., Postle, A. D., . . . the U-BIOPRED Study Group. (2013). Application of ’omics technologies to biomarker discovery in inflammatory lung diseases. European Respiratory Journal. https://doi.org/10.1183/09031936.00078812

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.